Magnesium oxide and Relpax drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Magnesium oxide (magnesium) and Relpax (eletriptan hydrobromide). Common drug interactions include anxiety among females and arthralgia among males.

The phase IV clinical study analyzes what interactions people have when they take Magnesium oxide and Relpax. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Magnesium oxide?

Magnesium oxide has active ingredients of magnesium. It is often used in migraine. eHealthMe is studying from 19,022 Magnesium oxide users. Check the latest studies of Magnesium oxide.

What is Relpax?

Relpax has active ingredients of eletriptan hydrobromide. It is often used in migraine. eHealthMe is studying from 9,259 Relpax users. Check the latest studies of Relpax.

On Aug, 02, 2026

24 people who take Magnesium oxide and Relpax together, and have interactions are studied.

Magnesium oxide and Relpax drug interactions.

What are the common drug interactions of Magnesium Oxide and Relpax, by gender? *:

female:

Anxiety
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Asthenia (weakness)
Drug intolerance (drug sensitivity)
Gait disturbance
Influenza
Metal poisoning
Mood altered (changes in mood)
Nasopharyngitis (inflammation of the nasopharynx)
Nervous system disorder (a general class of medical conditions affecting the nervous system)

male:

Arthralgia (joint pain)
Back pain
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Gastric disorder (disease of stomach)
Hip arthroplasty
Hospitalisation

What are the common drug interactions of Magnesium Oxide and Relpax, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Pain in extremity
Drug ineffective

40-49:

Influenza
Mood altered (changes in mood)
Haemorrhoids (a swollen vein or group of veins in the region of the anus)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Nausea (feeling of having an urge to vomit)
Pharyngitis (inflammation of the pharynx, causing a sore throat)
Pyrexia (fever)
Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 25.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 20.83%
Immunodeficiency Common Variable: 5 people, 20.83%
Primary Immunodeficiency Syndrome: 4 people, 16.67%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 16.67%
Asthma: 3 people, 12.50%
Pain: 3 people, 12.50%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 2 people, 8.33%
Combined Immunodeficiency: 2 people, 8.33%
Constipation: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Magnesium oxide and Relpax?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously